Cardiff Oncology Inc

Insider Buying Week 12-13-24 When does the Hammer Come Down?

by

I’d like to say I saw something last week that was sexy and showed a lot of potential.   Maybe I’m missing it and its staring right at you but you have to rely on more than insider buying to validate your purchase. I said that to myself and despite that I bought the management line that Dave and Busters didn’t need revenue growth but could rely on more efficient operations. Then the CEO quits two months later for a better job? Class action attorneys, you can include me on your mailer. Market momentum stalled last week. The 10-year Treasury sold … Read more

The Bold, the Inexplicable and the Good Soldiers- Insider Buying Week 9-17-21

by

For trade, details click on this link to the trades.  There were quite a few buys last week and it took me longer than usual to update it. Also, I will provide a brief recap of the conversation I had with the Chief Medical Officer, Alexander A. Zukiwski at Casi Pharmaceuticals. Casi is a U.S. NASDAQ-listed biotech selling exclusively to the increasingly affluent Chinese middle class.  CASI is a penny stock that will turn into $dollars if things pan out the way I think. They have one approved revenue-producing product with an exciting pipeline. There is a high probability they … Read more